A detailed history of International Biotechnology Trust PLC transactions in Erasca, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 1,926,000 shares of ERAS stock, worth $4.78 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
1,926,000
Previous 1,426,000 35.06%
Holding current value
$4.78 Million
Previous $3.94 Million 3.58%
% of portfolio
1.29%
Previous 1.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.97 - $2.91 $985,000 - $1.46 Million
500,000 Added 35.06%
1,926,000 $3.79 Million
Q1 2023

May 18, 2023

BUY
$2.74 - $4.44 $3.91 Million - $6.33 Million
1,426,000 New
1,426,000 $4.29 Million

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $303M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.